These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11701476)

  • 1. Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells.
    Levonen AL; Dickinson DA; Moellering DR; Mulcahy RT; Forman HJ; Darley-Usmar VM
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1846-51. PubMed ID: 11701476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione.
    Saito Y; Nishio K; Numakawa Y; Ogawa Y; Yoshida Y; Noguchi N; Niki E
    J Neurochem; 2007 Sep; 102(5):1625-1634. PubMed ID: 17697048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
    Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
    Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells.
    Liu JD; Lin SY; Ho YS; Pan S; Hung LF; Tsai SH; Lin JK; Liang YC
    Mol Carcinog; 2003 May; 37(1):16-24. PubMed ID: 12720296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
    Emi M; Maeyama K
    Biochem Pharmacol; 2004 Apr; 67(7):1259-67. PubMed ID: 15013841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism.
    Reyes-Martin P; Ramirez-Rubio S; Parra-Cid T; Bienes-Martínez R; Lucio-Cazana J
    Pharmacol Res; 2008 May; 57(5):344-50. PubMed ID: 18456507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling.
    Nencioni A; Lauber K; Grünebach F; Van Parijs L; Denzlinger C; Wesselborg S; Brossart P
    J Immunol; 2003 Nov; 171(10):5148-56. PubMed ID: 14607914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-deoxy-delta-12-14-PGJ2 regulates apoptosis induction and nuclear factor-kappaB activation via a peroxisome proliferator-activated receptor-gamma-independent mechanism in hepatocellular carcinoma.
    Okano H; Shiraki K; Inoue H; Yamanaka Y; Kawakita T; Saitou Y; Yamaguchi Y; Enokimura N; Yamamoto N; Sugimoto K; Murata K; Nakano T
    Lab Invest; 2003 Oct; 83(10):1529-39. PubMed ID: 14563954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Deoxy-Delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis.
    Lim SY; Jang JH; Na HK; Lu SC; Rahman I; Surh YJ
    J Biol Chem; 2004 Oct; 279(44):46263-70. PubMed ID: 15319433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy.
    Winnett G; van Hagen D; Schrey M
    Int J Cancer; 2003 Feb; 103(5):600-5. PubMed ID: 12494466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
    Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
    J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-Deoxy-prostaglandin J(2) inhibits PDGF-A and -B chain expression in human vascular endothelial cells independent of PPAR gamma.
    Zhang J; Fu M; Zhao L; Chen YE
    Biochem Biophys Res Commun; 2002 Oct; 298(1):128-32. PubMed ID: 12379230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiol antioxidant and thiol-reducing agents attenuate 15-deoxy-delta 12,14-prostaglandin J2-induced heme oxygenase-1 expression.
    Liu JD; Tsai SH; Lin SY; Ho YS; Hung LF; Pan S; Ho FM; Lin CM; Liang YC
    Life Sci; 2004 Mar; 74(19):2451-63. PubMed ID: 14998722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Deoxy-Delta(12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.
    Kim JW; Li MH; Jang JH; Na HK; Song NY; Lee C; Johnson JA; Surh YJ
    Biochem Pharmacol; 2008 Dec; 76(11):1577-89. PubMed ID: 18775681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prostaglandin-J(2) on VEGF synthesis depends on the induction of heme oxygenase-1.
    Jozkowicz A; Huk I; Nigisch A; Weigel G; Weidinger F; Dulak J
    Antioxid Redox Signal; 2002 Aug; 4(4):577-85. PubMed ID: 12230869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state.
    Katura T; Moriya T; Nakahata N
    Mol Pharmacol; 2010 Apr; 77(4):601-11. PubMed ID: 20086036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glutathionylation of p65 modulates NF-κB activity in 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂-treated endothelial cells.
    Lin YC; Huang GD; Hsieh CW; Wung BS
    Free Radic Biol Med; 2012 May; 52(9):1844-53. PubMed ID: 22387200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages.
    Janabi N
    J Immunol; 2002 May; 168(9):4747-55. PubMed ID: 11971025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells.
    Paumi CM; Wright M; Townsend AJ; Morrow CS
    Biochemistry; 2003 May; 42(18):5429-37. PubMed ID: 12731885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.